In 2025, Option Care Health delivered a remarkable 174.9% surge in revenue while operating income rose by a modest 5%, and net income slightly declined by 2%. Operating cash flow dropped by over 20%, despite increased capital expenditures reflecting infrastructure investment. This divergence points to margin pressures and regulatory cost headwinds within home infusion services. The company maintained a strong liquidity position, executing a sizable $310 million share buyback program, supported by debt refinancings that improved the capital structure. Governance efforts emphasize cybersecurity resilience, underpinning operational continuity in a complex regulatory environment.